Hylenex
Showing 1 - 25 of 38
Muscle Spasticity Trial in Baltimore (Hyaluronidase, Placebo)
Recruiting
- Muscle Spasticity
- Hyaluronidase
- Placebo
-
Baltimore, MarylandParia Arfa Fatollahkhani, MD, M.Sc.
Oct 28, 2022
Healthy Volunteers Trial in Philadelphia (dMAb AZD5396, dMAb AZD8076, Electroporation device)
Recruiting
- Healthy Volunteers
- dMAb AZD5396
- +4 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Nov 16, 2022
Healthy Volunteers Trial in Philadelphia (INO-A002, CELLECTRA® 2000, Dengue Fever Antibodies (IgG))
Completed
- Healthy Volunteers
- INO-A002
- +2 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Nov 7, 2022
Type 1 Diabetes Trial in Stanford (Hyaluronidase, Control)
Completed
- Type 1 Diabetes Mellitus
- Hyaluronidase
- Control
-
Stanford, CaliforniaStanford University
Sep 24, 2019
Dehydration Trial in Luanda (Hyaluronic Acid)
Completed
- Dehydration
- Hyaluronic Acid
-
Luanda, KenyaSagam Community Hospital
Mar 5, 2019
Psoriasis Trial in San Diego (Hylenex, Normal Saline)
Completed
- Psoriasis
- Hylenex
- Normal Saline
-
San Diego, CaliforniaUCSD Division of Dermatology
Dec 28, 2018
Chronic Wounds Trial in Harbin (HA35(L20200708MP07707, Ministry of Health, Mongolia)was freshly manufactured by mixing
Completed
- Chronic Wounds
- HA35(L20200708MP07707, Ministry of Health, Mongolia)was freshly manufactured by mixing hyaluronidase PH20 injectable solution (H31022111) and high-molecular-weight HA injectable solution (H20174089)
-
Harbin, Heilongjiang, ChinaFar East Hospital
Mar 1, 2023
Healthy Trial in Kalamazoo (recombinant human hyaluronidase)
Completed
- Healthy
- recombinant human hyaluronidase
-
Kalamazoo, MichiganJasper Clinic
Sep 18, 2018
Outcomes Study (FIGARO)
Completed
- Primary Immunodeficiency
- Secondary Immune Deficiency
- HyQvia
-
Paris, France
- +3 more
Mar 18, 2022
Type 1 Diabetes Trial in Chula Vista (Sham Injection, Recombinant human hyaluronidase PH20, Insulin aspart)
Completed
- Type 1 Diabetes Mellitus
- Sham Injection
- +3 more
-
Chula Vista, CaliforniaProfil Institute for Clinical Research
Feb 5, 2019
Type 1 Diabetes Trial in Chula Vista (Rapid Acting insulin with pre-treatment of rHuPH20, Sham injection)
Completed
- Type 1 Diabetes Mellitus
- Rapid Acting insulin with pre-treatment of rHuPH20
- Sham injection
-
Chula Vista, CaliforniaProfil Institute for Clinical Research
Jan 30, 2019
Type 1 Diabetes Trial in Chula Vista (Humalog, Humulin-R, Recombinant human hyaluronidase PH20 (rHuPH20))
Completed
- Type 1 Diabetes Mellitus
- Humalog
- +3 more
-
Chula Vista, CaliforniaProfil Institute for Clinical Research, Inc.
Feb 4, 2019
Diabetes Trial in San Antonio (Humalog, Humulin-R, Recombinant human hyaluronidase PH20 (rHuPH20))
Completed
- Diabetes Mellitus
- Humalog
- +2 more
-
San Antonio, TexasDiabetes and Glandular Disease Research, Inc.
Feb 4, 2019
Type 1 Diabetes Trial in United States (Commercial Hylenex® recombinant (hyaluronidase human injection), Precommercial Hylenex
Completed
- Type 1 Diabetes Mellitus
- Commercial Hylenex® recombinant (hyaluronidase human injection)
- +4 more
-
Concord, California
- +38 more
Oct 10, 2018
Dehydration Trial in United States (recombinant human hyaluronidase)
Completed
- Dehydration
- recombinant human hyaluronidase
-
Hartford, Connecticut
- +24 more
Oct 10, 2018
Dehydration, Cardiac Output, Pediatrics Trial in Nashville (Hylenex)
Completed
- Dehydration
- +2 more
- Hylenex
-
Nashville, TennesseeMonroe Carell Jr. Children's Hospital at Vanderbilt
Jan 8, 2018
Diabetes, Type 1 Trial in United States (Insulin lispro, recombinant human hyaluronidase PH20, Insulin aspart)
Completed
- Diabetes Mellitus, Type 1
- Insulin lispro
- +4 more
-
Escondido, California
- +18 more
Feb 5, 2019
Dermal Filler Trial (Hylenex)
Completed
- Dermal Filler
- Hylenex
- (no location specified)
May 15, 2017
Dehydration Trial (Oral rehydration fluid, Isotonic hydration fluid and recombinant human hyaluronidase)
Withdrawn
- Dehydration
- Oral rehydration fluid
- Isotonic hydration fluid and recombinant human hyaluronidase
- (no location specified)
May 5, 2017
Type 1 Diabetes Trial in Chula Vista (Insulin aspart, Recombinant human hyaluronidase PH20 (rHuPH20))
Completed
- Type 1 Diabetes Mellitus
- Insulin aspart
- Recombinant human hyaluronidase PH20 (rHuPH20)
-
Chula Vista, CaliforniaProfil Institute for Clinical Research
Jun 26, 2014
Healthy Trial in Chula Vista (Recombinant human hyaluronidase PH20 (rHuPH20), Insulin lispro, Insulin glulisine)
Completed
- Healthy
- Recombinant human hyaluronidase PH20 (rHuPH20)
- +3 more
-
Chula Vista, CaliforniaProfil Institute for Clinical Research, Inc.
Jun 12, 2014
Diabetes, Type 1 Trial in United States (Insulin Lispro, regular human insulin, recombinant human hyaluronidase PH20)
Completed
- Diabetes Mellitus, Type 1
- Insulin Lispro
- +3 more
-
Aurora, Colorado
- +7 more
Aug 28, 2014
Diabetes Trial in Chula Vista (Insulin Lispro, Regular Human Insulin, rHuPH20)
Completed
- Diabetes Mellitus
- Insulin Lispro
- +2 more
-
Chula Vista, CaliforniaProfil Institute for Clinical Research, Inc.
Jul 11, 2014
Diabetes, Type 2 Trial in Chula Vista (Humalog, Humulin-R, Recombinant human hyaluronidase PH20 (rHuPH20))
Completed
- Diabetes Mellitus, Type 2
- Humalog
- +2 more
-
Chula Vista, CaliforniaProfil Institute for Clinical Research, Inc.
Jul 30, 2014